Related references
Note: Only part of the references are listed.Risk factors for colistin-associated nephrotoxicity
Pinyo Rattanaumpawan et al.
JOURNAL OF INFECTION (2011)
Attenuation of Colistin Bactericidal Activity by High Inoculum of Pseudomonas aeruginosa Characterized by a New Mechanism-Based Population Pharmacodynamic Model
Juergen B. Bulitta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital
C. Andrew DeRyke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Steady-State Pharmacokinetics and BAL Concentration of Colistin in Critically Ill Patients After IV Colistin Methanesulfonate Administration
Roberto Imberti et al.
CHEST (2010)
Aerosolized plus Intravenous Colistin versus Intravenous Colistin Alone for the Treatment of Ventilator-Associated Pneumonia: A Matched Case-Control Study
Diamantis P. Kofteridis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Prevention of acute kidney injury and protection of renal function in the intensive care unit
Michael Joannidis et al.
INTENSIVE CARE MEDICINE (2010)
Predictors of acute kidney injury associated with intravenous colistin treatment
Jeong-Ah Kwon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients
Matthew E. Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections
Chien-Yu Cheng et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Intravenous colistin sulfate: A rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections
Jie Huang et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2010)
Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria
D. Plachouras et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical characteristics and risk factors of colistin-induced nephrotoxicity
Jieun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Clinical review: RIFLE and AKIN - time for reappraisal
Dinna N. Cruz et al.
CRITICAL CARE (2009)
Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: A prospective, open-label, uncontrolled study
Nikolaos Markou et al.
CLINICAL THERAPEUTICS (2008)
Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii
Joon Young Song et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2008)
Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance:: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model
Phillip J. Bergen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative, bacteria
Vicente Pintado et al.
JOURNAL OF INFECTION (2008)
Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia
Alex P. Betrosian et al.
JOURNAL OF INFECTION (2008)
Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand
Pornpan Koomanachai et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2007)
Safety and efficacy of colistin compared with imipenem in the treatment of ventilator-associated pneumonia: a matched case-control study
H. Kallel et al.
INTENSIVE CARE MEDICINE (2007)
Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections
M. E. Falagas et al.
CLINICAL MICROBIOLOGY AND INFECTION (2006)
Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU
Hatem Kallel et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Nephrotoxicity of intravenous colistin: a prospective evaluation
ME Falagas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:: a prospective cohort study
R Reina et al.
INTENSIVE CARE MEDICINE (2005)
Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
AS Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2005)
Toxicity after prolonged (more than four weeks) administration of intravenous colistin
ME Falagas et al.
BMC INFECTIOUS DISEASES (2005)
Colistin interactions with the mammalian urothelium
JR Lewis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
R Bellomo et al.
CRITICAL CARE (2004)
Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
N Markou et al.
CRITICAL CARE (2003)
Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin:: A comparison with imipenem-susceptible VAP
J Garnacho-Montero et al.
CLINICAL INFECTIOUS DISEASES (2003)